Literature DB >> 3069039

Endoscopic retrograde cholangiopancreatography (ERCP) and sphincterotomy (EST) after BII resection.

I Nordback1, I Airo.   

Abstract

We analysed the results of 437 endoscopic retrograde cholangiopancreatographies (ERCP) and 126 endoscopic sphincterotomies (EST) after gastric diversion surgery collected from the literature and from our hospital. The most difficult step in the procedure was duodenal intubation (90% success; range 33-95%). This greatly depended on the method of intestinal reconstruction. Poorest results were related to a long jejunal loop with entero-enterostomy (Braun's anastomosis). A final ERCP success rate was 74% (46-95%). EST could be performed in most of the cases (93%) indicated. Extraction of biliary calculi succeeded only infrequently. Insertion of biliary stents was possible. Special techniques of the procedure are discussed. It is concluded that ERCP and EST may also be performed after gastric surgery with varying success depending on the method of intestinal reconstruction. Both doctor and patient should be prepared to the possible use of alternative methods.

Entities:  

Mesh:

Year:  1988        PMID: 3069039

Source DB:  PubMed          Journal:  Ann Chir Gynaecol        ISSN: 0355-9521


  3 in total

1.  Utility of endoscopic retrograde cholangiopancreatography on biliopancreatic diseases in patients with Billroth II-reconstructed stomach.

Authors:  Yuji Sakai; Toshio Tsuyuguchi; Rintaro Mikata; Harutoshi Sugiyama; Shin Yasui; Masaru Miyazaki; Osamu Yokosuka
Journal:  World J Gastrointest Endosc       Date:  2017-03-16

2.  Parameters That May Be Used for Predicting Failure during Endoscopic Retrograde Cholangiopancreatography.

Authors:  Emre Balik; Tunc Eren; Metin Keskin; Sedat Ziyade; Turker Bulut; Yilmaz Buyukuncu; Sumer Yamaner
Journal:  J Oncol       Date:  2013-06-03       Impact factor: 4.375

3.  Endoscopic Retrograde Cholangiopancreatography Using a Dual-Lumen Endogastroscope for Patients with Billroth II Gastrectomy.

Authors:  Wei Yao; Yonghui Huang; Hong Chang; Ke Li; Xuebiao Huang
Journal:  Gastroenterol Res Pract       Date:  2013-05-27       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.